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• Assess the impact of drug-drug interaction alerts 
on pharmacists during order verification
Drug-Drug Interactions 
• A drug-drug interaction (DDI) occurs when one medication affects 
either the pharmacokinetics or pharmacodynamics of another 
medication
• These interactions can modify the therapeutic efficacy of a medication or 
increase potential risks 
• DDIs can result in preventable adverse drug events (ADEs), which can 
cause harm to patients
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Clinical Decision Support 
• A clinical decision support (CDS) system is a health information 
technology program that assists with clinical decision-making tasks
• CDS systems are capable of reducing the frequency of preventable 
ADEs
• Studies have found that only around 10% of the alerts fired by CDS 
systems are applicable in all the circumstances they fire
• Despite their benefits, medication-related alerts are often ignored and 
have high override rates
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Alert Fatigue
• Alert fatigue occurs when both important and non-important alerts are 
ignored because of the mental exhaustion and time required to look 
through too many alerts
• Such nuisance alerts interrupt workflow and distract from patient care, 
leading to the routine override of alerts
• There is a lack of evidence when it comes to deciding which alerts
should be removed and which should be kept as part of the CDS system
• The decision to manage these alerts is usually institution-specific
6
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Setting
Baptist Health South Florida (BHSF) system-wide initiative  
• Baptist Hospital of Miami
• Doctors Hospital
• Corporate Enterprise 
• Fishermen’s Hospital
• Homestead Hospital
• Miami Cancer Institute 
• Mariners Hospital 
• South Miami Hospital 




• Identify common DDI alerts that are consistently being overridden by 
pharmacists
Secondary objectives: 
• Decrease the quantity of clinically insignificant DDI alerts firing to 
pharmacists




Top 50 alerts were reviewed by the Medication Safety and Clinical Optimization committees
Top 50 alerts within this list were selected 
Using Excel, the list was filtered to include only “major” alerts being overridden at least 95% of 
the time
Lights On Network® was used to identify the DDI alerts firing in November 2019
9
Methodology: Survey 
Post-implementation survey was sent the last two weeks of March 
Pharmacists were provided a few weeks to interact with the updates to the system
Alerts were removed from Cerner on February 28th
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Total Alerts Removed = 23/50
Results: DDI Alerts (November vs March)
DDI Alerts November 2019 March 2020 Difference
Total number of alerts firing 161,758 99,329 39%
• Alerts being overridden 140,948 (87%) 73,095 (74%) 13%
• Top 50 DDI alerts 
accounted for 73,873 (46%)
23,182 (23%) 23%
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Nov-19 Dec-19 Jan-20 Feb-20 Mar-20
Alerts Fired % overriden% ove ridden 
Survey Demographics 
Characteristic Pre-implementation (n=94) Post-implementation (n=55) 
BHSF entity: 
• Baptist Hospital of Miami 30 (32%) 19 (35%)
• South Miami Hospital 26 (28%) 18 (33%)
• West Kendall Baptist Hospital 15 (16%) 6 (11%)
• Homestead Hospital 11 (12%) 4 (7%)
• Miami Cancer Institute 7 (7%) 4 (7%)
• Corporate Enterprise 3 (3%) 3 (5%)
• Doctors Hospital 2  (2%) 1 (2%) 
Amount of years working for BHSF: 
• Less than a year 30 (32%) 13 (24%)
• 1 to 5 years 15 (17%) 22 (41%)
• 6 to 10 years 17 (18%) 6 (11%) 
• More than 10 years 31 (33%) 13 (24%) 
Current position: 
• Clinical Pharmacist 1 or II 54 (57%) 31 (56%)
• Clinical Specialist I or II 16 (18%) 11 (20%)
• Clinical Coordinator or Clinical Manager 5 (5%) 2 (4%)
• Other 19 (20%) 11 (20%)
Amount of hours per week doing order entry: 
• Less than 10 hours 21 (22%) 15 (28%)
• Between 10 to 20 hours 26 (28%) 10 (19%)
• Between 21 to 40 hours 36 (38%) 25 (46%)
• More than 40 hours 11 (12%) 4 (7%) 
Pharmacist Survey
Survey Question
Mean ± S.D. Pre-
Implementation Likert 
Scale* 
Mean ± S.D. Post-
Implementation Likert 
Scale* 
The DDI alerts fired by Cerner provide clinically 
relevant information that is useful to me 3.50 ± 1.0 3.70 ± 1.0
The number of DDI alerts being fired by Cerner is 
just right 2.50 ± 1.2 3.00 ± 1.1
I have the time during order entry/verification to 
review every DDI alert fired by Cerner 2.65 ± 1.2 2.80 ± 1.1
BHSF is currently trying to optimize DDI alerts 3.60 ± 1.0 4.20 ± 0.6
18
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I estimate that I override 
approximately ____% of DDI alerts:
Survey 
Responses Percentage
Less than 40% 17 18%
Between 41-60% 18 19%
Between 61-80% 41 44%
More than 80% 18 19%
Grand Total 94 100%
I estimate that I override 
approximately ____% of DDI alerts:
Survey 
Responses Percentage
Less than 40% 7 13%
Between 41-60% 15 27%
Between 61-80% 24 44%
More than 80% 9 16%



























• There was a decrease in both the number of DDI alerts fired and percentage of alerts 
being overridden in the month of March 
• After implementation, more pharmacists agreed or strongly agreed that the number of 
DDI alerts being fired by Cerner is just right (23% pre vs 39% post)
• Another area with demonstrated improvement is the perception that our system is 
working to optimize drug-drug interaction alerts (55% pre vs 89% post) 
• Even though the percentage of alerts overridden decreased by 13% after 
implementation, pharmacist perception regarding the amount of alerts being 
overridden did not drastically change
22
Conclusion
• More needs to be done to improve alert fatigue in our system
• Not every alert with a high override should be removed 




• Short time period
• Due to COVID-19, institutions had a lower census in March
• Possibly biased results in the post-implementation survey
• Limited amount of responses for post-implementation survey
• Additional DDI alerts were turned off in certain PowerPlans
24
Assessment Question
Which of the following is not true regarding drug-drug 
interaction alerts?
A. Only around 10% of DDI alerts are applicable in all the instances they 
fire 
B. Alert fatigue is a safety concern because it can lead to important 
alerts being ignored 
C. A continuous process to evaluate DDI alerts is the best practice to 
reduce alert fatigue 
D. Alert fatigue is only a concern for physicians 
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Assessment Answer
Which of the following is not true regarding drug-drug 
interaction alerts?
A. Only around 10% of DDI alerts are applicable in all the instances they 
fire 
B. Alert fatigue is a safety concern because it can lead to important 
alerts being ignored 
C. A continuous process to evaluate DDI alerts is the best practice to 
reduce alert fatigue 
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